# Vishnukamal Golla

> Vishnukamal "Kamal" Golla, MD, MPH, is Evolent's SVP and CMO of Oncology, a board-certified urologist, Duke medical faculty member, health-policy researcher, and 2026 40 Under 40 in Cancer honoree. His career connects clinical training, payment reform, digital tools, and care navigation around one practical question: how can incentives and infrastructure make complex specialty care more coordinated, affordable, and accountable to outcomes?

- **Role:** SVP, CMO Oncology at Evolent
- **Organizations:** Evolent, Duke University School of Medicine, Duke-Margolis Institute for Health Policy, Durham Veterans Affairs Health Care System, UCLA Health, University of Texas Health Science Center at Houston, University of Southern California
- **Education:** BA, University of Southern California, MD, MPH, University of Texas Health Science Center at Houston, Urology residency, University of California, Los Angeles, National Clinician Scholars Program fellowship, Duke University
- **Known for:** Named to the Association for Value-Based Cancer Care's 2026 40 Under 40 in Cancer class., Board certified in urology., Received an American Urological Association Residency Research Award for 2018-2019.

## Career timeline

- **2010** — Completed a BA at the University of Southern California.
- **2015** — Completed MD and MPH degrees at the University of Texas Health Science Center at Houston.
- **2015-2021** — Completed urology residency training at UCLA.
- **2018-2019** — Received an American Urological Association Residency Research Award supported by the Kahlert Foundation.
- **2021-2023** — Served as a National Clinician Scholars Program fellow at Duke University.
- **2023** — Co-authored a roadmap on value-based payment for independent urology practices and published research on telehealth patterns in primary and onco-primary care.
- **2024** — Appeared in Evolent interviews and on Health Care Rounds as Senior Medical Director for Value Transformation.
- **2025** — Appeared publicly as Evolent's VP of Clinical Technology and Performance and discussed cancer care navigation on the Empowered Patient Podcast.
- **2026** — Named to the Association for Value-Based Cancer Care's 2026 40 Under 40 in Cancer class; listed as SVP, CMO Oncology at Evolent.

## Achievements

- Named to the Association for Value-Based Cancer Care's 2026 40 Under 40 in Cancer class.
- Board certified in urology.
- Received an American Urological Association Residency Research Award for 2018-2019.
- Received the H.H. Lee Surgical Research Award, according to his Duke profile.
- Duke lists 47 publications on his faculty profile.
- Serves as a Medical Assistant Professor in Duke's Department of Urology and as core faculty at the Duke-Margolis Institute for Health Policy.

## Latest updates

- **2026-05** — Named to the 2026 40 Under 40 in Cancer class by the Association for Value-Based Cancer Care.
- **2025-10** — Discussed personalized cancer care navigation and a future precision-navigation model on the Empowered Patient Podcast.
- **2025-09** — Co-authored 'Payment Bundles for Prostatectomy: A New Way to Improve Value for Prostate Cancer Care' in Urology.
- **2025-01** — Appeared on the BRight Minds in Healthcare Delivery podcast to discuss the future of value-based specialty care.
- **2024-09** — Appeared on the Health Care Rounds podcast to discuss fragmented care and value-based specialty care.

## Links

- Website: https://evolent.com
- LinkedIn: https://www.linkedin.com/in/vishnukamal-golla-a46777219

---

Profile page: https://yespress.io/vishnukamal-golla
Published by YesPress — https://yespress.io
Last updated: 2026-08-14